Blood Culture Positivity and Adverse Outcomes among Neonates with Jaundice in a Resource-Limited NICU: Implications for Antibiotic Stewardship
الشريط الجانبي للمقالة
محتوى المقالة الرئيسي
الملخص
Background: Neonatal jaundice is a common cause of admission to neonatal intensive care units (NICUs), particularly in low-resource settings. Because jaundice may be an early manifestation of neonatal sepsis, empiric antibiotic therapy is frequently initiated, often in the absence of microbiological confirmation. The clinical significance of blood culture positivity in jaundiced neonates, however, remains insufficiently characterized.
Objective: To evaluate the association between blood culture positivity and adverse clinical outcomes among neonates admitted with jaundice and to assess implications for antibiotic stewardship in a resource limited NICU.
Methods: This retrospective observational cohort study included 89 neonates admitted with jaundice to a tertiary NICU in Tripoli, Libya, between January and June 2025. Blood culture positivity was the primary exposure. The primary outcome was a composite adverse outcome comprising late-onset sepsis, rebound jaundice, neurological complications, or in-hospital mortality. Associations were evaluated using bivariate analysis and multivariable logistic regression adjusting for prematurity and low birth weight.
Results: Blood cultures were obtained in 38 neonates (42.7%), of whom 13 (14.6%) had culture-confirmed bacteremia. Klebsiella spp. and Staphylococcus spp. were the most frequently isolated organisms. All neonates received empiric antibiotics at admission. Culture-positive infants had significantly higher rates of early-onset sepsis compared with culture-negative or untested infants (38.5% vs. 5.3%, p<0.01). After adjustment, blood culture positivity remained independently associated with the composite adverse outcome (adjusted OR 28.4; 95% CI 7.9–102.0; p<0.001).
Conclusion: Blood culture positivity identifies a high-risk subgroup of jaundiced neonates with substantially increased odds of adverse outcomes. Despite universal empiric antibiotic use, more than half of infants were not cultured, highlighting an important stewardship gap. Strengthening culture sampling, early reassessment and antibiotic de-escalation protocols is essential to improve neonatal outcomes in resource-limited NICUs.
تفاصيل المقالة
هذا العمل مرخص بموجب Creative Commons Attribution-ShareAlike 4.0 International License.
المراجع
Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics. Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2011;128:e1046–52.
Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med (Lond). 2017 Dec 02;78(12):699-704.
Das B, Suma HR, Rasalkar KP, Nasar SA, Devi CS, Gandham Rajeev GR. Biochemical evaluation of serum bilirubin fractions and liver function tests in sepsis neonates with hyperbilirubinemia. 2016;7(1):38–41.
Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr 2017;171:365-71. 10.1001/jamapediatrics.2016.4678.
Ting JY, Synnes A, Roberts A, et al. Association of antibiotic utilization and neonatal outcomes in very-low-birth-weight infants without proven sepsis. JAMA Pediatrics 2016;170:1181-7. 10.1001/jamapediatrics.2016.2132
Ting JY, Synnes A, Roberts A, et al. Association of antibiotic utilization and neurodevelopmental outcomes among extremely low gestational age neonates without proven sepsis or necrotizing enterocolitis. Am J Perinatol 2018;35:972-8. 10.1055/s-0038-1632390
Lu C, Liu Q, Yuan H, et al. Implementation of the smart use of antibiotics program to reduce unnecessary antibiotic use in a neonatal ICU: a prospective interrupted time-series study in a developing country. Crit Care Med 2019;47:e1-7. 10.1097/CCM.0000000000003463.
Das B, Suma HR, Rasalkar KP, Nasar SA, Devi CS, Gandham Rajeev GR. Biochemical evaluation of serum bilirubin fractions and liver function tests in sepsis neonates with hyperbilirubinemia 2016;7(1):38–41.
Panigrahi P, Choudhury S, Nanda P, et al. Neonatal sepsis in a resource-limited setting: causative microorganisms and antimicrobial susceptibility profile. Front Pediatr. 2022;10:909983.
Ashraf F, Ali A. Blood culture positivity and antimicrobial resistance patterns in neonatal sepsis: a prospective observational study. J Neonatal Surg. 2020;9(3):35.
Abdullahi A, Yusuf A, Hassan M, et al. Prevalence and risk factors for neonatal jaundice: a multicentre analytical cross-sectional study at three neonatal intensive care units in Mogadishu, Somalia. BMC Pediatr. 2025;25(1):xx–xx.
Asaye S, Chanie MG, Bereda G. Hyperbilirubinemia and associated factors among neonates admitted to the neonatal care unit in Jimma Medical Center, Southwest Ethiopia. Pediatr Health Med Ther. 2023;14:215–23.
Asmare DA, Biniyam M, Birtukan E, Wondimu W, Mintesinot A, Getachew K, et al. Neonatal jaundice and its association with sepsis, birth trauma, and prolonged labor: A systematic review and .meta-analysis. Heliyon. 2024;10(5):e02661
Belide S, Uddin MW, Kumar S, Sethi RK, Diwakar K, Jhajra S. Clinical study to determine the predictability of significant rebound hyperbilirubinemia in neonates after phototherapy and conditions likely to be associated with it: Prospective observational study in a teaching hospital in Eastern India. Journal of Family Medicine and Primary Care [Internet]. 2023 Dec [cited 2025 May 22];12(12):3362. Available from: https://journals.lww.com/jfmpc/fulltext/2023/12120/clinica l_study_to_determine_the_predictability_of.57.aspx
Shapiro SM, Nakamura H. Bilirubin-induced neurologic damage—mechanisms and management approaches. Semin Fetal Neonatal Med. 2015;20(1):20-25. doi:10.1016/j.siny.2014.12.002.
National Institute for Health and Care Excellence (NICE). Jaundice in newborn babies under 28 days: recognition and management [Internet]. London: NICE; 2023 Oct [cited 2025 Dec 10]. Available from: www.nice.org.uk
Wang H, Li Z, Chen X, et al. Clinical and microbiological profile of babies born with risk of neonatal sepsis in Xuzhou Central Hospital (2014–2015). Clin Pediatr (Phila). 2017;56(6):560–6.
Zaidi AKM, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Lancet. 2005;365(9465):1175-1188. doi:10.1016/S0140-6736(05)71846-4.